School of Biomedical Sciences & Pharmacy, University of Newcastle & Vaccine and Asthma (VIVA) Program, Hunter Medical Research Institute, Callaghan, NSW, Australia.
School of Medicine & Public Health, University of Newcastle, Callaghan, NSW, Australia.
Eur J Clin Invest. 2015 Dec;45(12):1350-9. doi: 10.1111/eci.12548. Epub 2015 Nov 9.
Gastrointestinal conditions may be broadly classified into two: organic and functional disease, with functional disorders accounting for the majority of patients with chronic gastrointestinal symptoms. Functional gastrointestinal disorders (FGIDs) present with no obvious pathology or well-accepted biochemical mechanism and, as such, treatment strategies are limited and focus on symptoms rather than cure. Irritable bowel syndrome and functional dyspepsia are the most widely recognised FGIDs, and there is a growing body of evidence to suggest an underlying inflammatory phenotype in subsets with these conditions. Here, we discuss the current knowledge of immune involvement in FGIDs and the commonalities between the different manifestations of FGIDs and propose a new hypothesis, potentially defining an underlying immunopathological basis of these conditions.
器质性疾病和功能性疾病,其中功能性疾病占慢性胃肠道症状患者的大多数。功能性胃肠道疾病(FGIDs)无明显病理或公认的生化机制,因此治疗策略有限,主要针对症状而非治愈。肠易激综合征和功能性消化不良是最广为人知的 FGIDs,越来越多的证据表明,这些疾病的亚组存在潜在的炎症表型。在这里,我们讨论了免疫参与 FGIDs 的现有知识,以及不同 FGIDs 表现之间的共同性,并提出了一个新的假说,可能为这些疾病确定了一个潜在的免疫病理基础。